0001225208-17-004769.txt : 20170227 0001225208-17-004769.hdr.sgml : 20170227 20170227181059 ACCESSION NUMBER: 0001225208-17-004769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170223 FILED AS OF DATE: 20170227 DATE AS OF CHANGE: 20170227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CANGIALOSI LORETTA V CENTRAL INDEX KEY: 0001174449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 17643687 MAIL ADDRESS: STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY STREET 2: 235 EAST 42ND ST. CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4.xml X0306 4 2017-02-23 0000078003 PFIZER INC PFE 0001174449 CANGIALOSI LORETTA V PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Sr. Vice President, Controller Common Stock 2017-02-23 4 M 0 36408.0000 21.0300 A 102611.0000 D Common Stock 2017-02-23 4 A 0 4462.0000 0.0000 A 107073.0000 D Common Stock 2017-02-23 4 F 0 6996.0000 34.0600 D 100077.0000 D Common Stock 2017-02-23 4 F 0 17627.0000 32.4900 D 82450.0000 D Common Stock 1201.0000 I By Rule 16b-3 Plan Stock Appreciation Rights 21.0300 2017-02-23 4 M 0 36408.0000 0.0000 D 2017-02-23 2017-02-23 Common Stock 36408.0000 0.0000 D Stock Appreciation Rights 34.0600 2017-02-23 4 A 0 24351.0000 0.0000 A 2022-02-23 2022-02-23 Common Stock 24351.0000 24351.0000 D Stock Appreciation Rights 34.0600 2017-02-23 4 A 0 20216.0000 0.0000 A 2024-02-23 2024-02-23 Common Stock 20216.0000 20216.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Susan E. Grant, by power of atty., for Loretta V. Cangialosi 2017-02-27